Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

Spelman, Tim; Meyniel, Claire; Ignacio Rojas, Juan; Lugaresi, Alessandra; Izquierdo, Guillermo; Grand'Maison, Francois; BOZ, CAVİT; Alroughani, Raed; Havrdova, Eva; Horakova, Dana; Iuliano, Gerardo; Duquette, Pierre; Terzi, Murat; Grammond, Pierre; Hupperts, Raymond; Lechner-Scott, Jeannette; Oreja-Guevara, Celia; Pucci, Eugenio; Verheul, Freek; Fiol, Marcela; Van Pesch, Vincent; Cristiano, Edgardo; Petersen, Thor; Moore, Fraser; Kalincik, Tomas; Jokubaitis, Vilija; Trojano, Maria; Butzkueven, Helmut

doi:10.1177/1352458516679893

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

Spelman T., Meyniel C., Ignacio Rojas J., Lugaresi A., Izquierdo G., Grand'Maison F., ...More

MULTIPLE SCLEROSIS JOURNAL, vol.23, no.10, pp.1346-1357, 2017 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 23 Issue: 10
Publication Date: 2017
Doi Number: 10.1177/1352458516679893
Journal Name: MULTIPLE SCLEROSIS JOURNAL
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1346-1357
Keywords: Nomogram, clinically isolated syndrome, clinically definite multiple sclerosis, second attack, disease-modifying drugs, MRI, CSF, MS, CIS, MULTIPLE-SCLEROSIS, DIAGNOSTIC-CRITERIA, CEREBROSPINAL-FLUID, INTERFERON BETA-1A, OLIGOCLONAL BANDS, MRI CRITERIA, CONVERSION, DISABILITY, ATTACKS
Open Archive Collection: AVESIS Open Access Collection
Ondokuz Mayıs University Affiliated: Yes

Abstract

Background: Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient at highest risk of early second attack and could benefit the most from early disease-modifying drugs (DMDs).